Non-Invasive Cancer Diagnostics Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
8859 | Date :
Jan, 2023 | Pages :
186 | Region : Global |
Publisher : 99 Strategy
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization\'s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The Global Non-Invasive Cancer Diagnostics Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Non-Invasive Cancer Diagnostics Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
CTCs
CTNAS
Exosomes
In Market segmentation by applications :
Blood
Urine
Saliva
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Non-Invasive Cancer Diagnostics Market for the forecast period 2023-2030?
• What are the driving forces in the Non-Invasive Cancer Diagnostics Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Non-Invasive Cancer Diagnostics industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (2020-2030)
1.3.2 CTCs
1.3.3 CTNAS
1.3.4 Exosomes
1.4 Market Segment by Application
1.4.1 Global Non-Invasive Cancer Diagnostics Market Share by Application (2020-2030)
1.4.2 Blood
1.4.3 Urine
1.4.4 Saliva
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2015-2030
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2015-2030
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions 2018 - 2022
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers 2018 - 2022
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2018 - 2022)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Key Manufacturers Non-Invasive Cancer Diagnostics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.6 Key Manufacturers Non-Invasive Cancer Diagnostics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 CTCs Sales and Revenue (2018 - 2022)
4.1.2 CTNAS Sales and Revenue (2018 - 2022)
4.1.3 Exosomes Sales and Revenue (2018 - 2022)
4.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type
4.3 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type
4.4 Non-Invasive Cancer Diagnostics Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Sales by Application
6 United States
6.1 United States Non-Invasive Cancer Diagnostics Breakdown Data by Company
6.2 United States Non-Invasive Cancer Diagnostics Breakdown Data by Type
6.3 United States Non-Invasive Cancer Diagnostics Breakdown Data by Application
7 European Union
7.1 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Company
7.2 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Type
7.3 European Union Non-Invasive Cancer Diagnostics Breakdown Data by Application
8 China
8.1 China Non-Invasive Cancer Diagnostics Breakdown Data by Company
8.2 China Non-Invasive Cancer Diagnostics Breakdown Data by Type
8.3 China Non-Invasive Cancer Diagnostics Breakdown Data by Application
9 Rest of World
9.1 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Company
9.2 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Type
9.3 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Application
9.4 Rest of World Non-Invasive Cancer Diagnostics Breakdown Data by Countries
9.4.1 Rest of World Non-Invasive Cancer Diagnostics Sales by Countries
9.4.2 Rest of World Non-Invasive Cancer Diagnostics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Gen-Probe Inc
10.1.1 Gen-Probe Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.1.4 Non-Invasive Cancer Diagnostics Product Introduction
10.1.5 Gen-Probe Inc Recent Development
10.2 Digene Corporation
10.2.1 Digene Corporation Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.2.4 Non-Invasive Cancer Diagnostics Product Introduction
10.2.5 Digene Corporation Recent Development
10.3 Quest Diagnostics Inc
10.3.1 Quest Diagnostics Inc Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.3.4 Non-Invasive Cancer Diagnostics Product Introduction
10.3.5 Quest Diagnostics Inc Recent Development
10.4 Cancer, Genetics Inc
10.4.1 Cancer, Genetics Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.4.4 Non-Invasive Cancer Diagnostics Product Introduction
10.4.5 Cancer, Genetics Inc Recent Development
10.5 BIOVIEW Inc
10.5.1 BIOVIEW Inc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.5.4 Non-Invasive Cancer Diagnostics Product Introduction
10.5.5 BIOVIEW Inc Recent Development
10.6 AVIVA Biosciences Corporation
10.6.1 AVIVA Biosciences Corporation Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.6.4 Non-Invasive Cancer Diagnostics Product Introduction
10.6.5 AVIVA Biosciences Corporation Recent Development
10.7 Laboratory Corporation of America Holdings (LabCorp)
10.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.7.4 Non-Invasive Cancer Diagnostics Product Introduction
10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
10.8 A&G Pharmaceutical
10.8.1 A&G Pharmaceutical Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.8.4 Non-Invasive Cancer Diagnostics Product Introduction
10.8.5 A&G Pharmaceutical Recent Development
10.9 Affymetrix Inc
10.9.1 Affymetrix Inc Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.9.4 Non-Invasive Cancer Diagnostics Product Introduction
10.9.5 Affymetrix Inc Recent Development
10.10 Precision Therapeutics
10.10.1 Precision Therapeutics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Non-Invasive Cancer Diagnostics
10.10.4 Non-Invasive Cancer Diagnostics Product Introduction
10.10.5 Precision Therapeutics Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Non-Invasive Cancer Diagnostics Sales Channels
11.2.2 Non-Invasive Cancer Diagnostics Distributors
11.3 Non-Invasive Cancer Diagnostics Customers
12 Market Forecast
12.1 Global Non-Invasive Cancer Diagnostics Sales and Revenue Forecast 2020-2030
12.2 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type
12.3 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application
12.4 Non-Invasive Cancer Diagnostics Forecast by Regions
12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2020-2030
12.4.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.